Patient Age Group

Edit Profile

News & Events

  • Unexpected factor contributes to melanoma risk in red-haired, fair-skinned individuals

    The elevated risk of melanoma among people with red hair and fair skin may be caused by more than just a lack of natural protection against ultraviolet radiation. Resarchers at the MGH Cutaneous Biology Research Center and Cancer Center have found that the type of skin pigment predominantly found in red-haired, fair-skinned individuals may itself contribute to the development of melanoma.

  • Tumor microenvironment helps skin cancer cells resist drug treatment

    New research by a team from the Broad Institute, Dana-Farber Cancer Institute, and Massachusetts General Hospital suggests that how cancer evade drug treatment may depend on the interplay between tumor cells and their healthy counterparts.

  • Claflin Awards fund innovation

    Designed to sustain productivity of women scientists at the MGH who are balancing their research careers with the responsibilities of raising a family, the Claflin Distinguished Scholar Awards annually are presented to junior faculty members at the MGH.

  • Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment

    Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study by MGH researchers.

  • Luncheon raises funds and skin cancer awareness

    MGH Hotline 5.08.09 Approximately 100 people attended the Friends of the MGH Cancer Center's annual fundraising forum April 22 in the Bulfinch Tents. This year's event featured MGH skin cancer experts David Fisher, MD, PhD, chief of the Department of Dermatology and director of the Center for Melanoma, left, and Jennifer Wargo, MD, of the Department of Surgery.